|
US6538037B2
(en)
*
|
1991-01-08 |
2003-03-25 |
Bone Care International, Inc. |
Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
|
|
US20040009958A1
(en)
*
|
1991-01-08 |
2004-01-15 |
Bone Care International, Inc. |
Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
|
|
US5763429A
(en)
*
|
1993-09-10 |
1998-06-09 |
Bone Care International, Inc. |
Method of treating prostatic diseases using active vitamin D analogues
|
|
TW382595B
(en)
*
|
1993-10-15 |
2000-02-21 |
Merck & Co Inc |
Pharmaceutical composition for use in arresting and reversing androgenic alopecia
|
|
US5547957A
(en)
*
|
1993-10-15 |
1996-08-20 |
Merck & Co., Inc. |
Method of treating androgenic alopecia with 5-α reductase inhibitors
|
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US6566353B2
(en)
*
|
1996-12-30 |
2003-05-20 |
Bone Care International, Inc. |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
|
|
US20020128240A1
(en)
*
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
AU750451B2
(en)
*
|
1997-02-13 |
2002-07-18 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US20030129194A1
(en)
*
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
|
US6087350A
(en)
*
|
1997-08-29 |
2000-07-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
|
|
US20020076442A1
(en)
*
|
1997-09-02 |
2002-06-20 |
Martin Burke |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
US6849616B1
(en)
*
|
1998-03-27 |
2005-02-01 |
Pharmacia Italia S.P.A. |
Methods to potentiate intravenous estramustine phosphate
|
|
EP2340840B1
(en)
|
1998-03-27 |
2012-08-29 |
Oregon Health Sciences University |
Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
|
|
US6479474B2
(en)
*
|
1999-07-08 |
2002-11-12 |
Wisconsin Alumni Research Foundation |
Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
|
|
IL153378A0
(en)
*
|
2000-07-18 |
2003-07-06 |
Bone Care Internat Inc |
STABILIZED 1alpha-HYDROXY VITAMIN D
|
|
AU2002228648A1
(en)
*
|
2000-11-16 |
2002-05-27 |
Pharmacia And Upjohn Company |
Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
|
|
US20040071789A1
(en)
*
|
2002-02-14 |
2004-04-15 |
Baron John A |
Calcium supplementation to reduce prostate cancer risk
|
|
US7129230B2
(en)
*
|
2001-03-12 |
2006-10-31 |
Nestec S.A. |
Method and product for treating cancer in pets
|
|
US20030191093A1
(en)
*
|
2001-12-03 |
2003-10-09 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20080260834A1
(en)
*
|
2002-08-20 |
2008-10-23 |
Martin Burke |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
AU2003273318A1
(en)
*
|
2002-09-12 |
2004-04-30 |
University Of Chicago |
Monitoring and diagnosis of gastric emptying and gastroparesis
|
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
|
WO2004047673A2
(en)
*
|
2002-11-21 |
2004-06-10 |
Novacea, Inc. |
Treatment of liver disease with active vitamin d compounds
|
|
JP2007501864A
(ja)
*
|
2003-06-11 |
2007-02-01 |
ノバセア インコーポレイティッド |
活性ビタミンｄ化合物単独または他の治療薬との併用による、免疫介在疾患の治療法
|
|
CA2528359A1
(en)
*
|
2003-06-11 |
2004-12-23 |
Novacea, Inc. |
Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
|
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
WO2005011660A1
(en)
*
|
2003-07-29 |
2005-02-10 |
Abbott Laboratories |
Use of vitamin d to down regulate the renin-angiotensin-aldosterone system
|
|
EP1664784A1
(en)
*
|
2003-09-17 |
2006-06-07 |
Guava Technologies, Inc. |
Compositions and methods for analysis of target analytes
|
|
PT103177A
(pt)
*
|
2003-09-24 |
2005-03-31 |
Bioxell Spa |
1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
|
|
EP1663250A4
(en)
*
|
2003-09-24 |
2006-12-20 |
Bioxell Spa |
TREATMENT OF MALFUNCTION OF BLADDER
|
|
US20070275934A1
(en)
*
|
2004-05-10 |
2007-11-29 |
Curd John G |
Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
|
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
|
JP2008519808A
(ja)
*
|
2004-11-12 |
2008-06-12 |
ビオエクセル エスピーエー |
膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用
|
|
EP1945185B1
(en)
*
|
2005-10-12 |
2016-02-03 |
Proventiv Therapeutics, LLC |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
WO2007070494A2
(en)
*
|
2005-12-12 |
2007-06-21 |
Women & Infants Hospital Of Rhode Island |
Heterocycles and derivatives thereof and methods of manufacture and therapeutic use
|
|
SI1993559T1
(sl)
|
2006-02-03 |
2017-01-31 |
Opko Renal, Llc |
Zdravljenje nezadostnosti in pomanjkanja vitamina D s 25-hidroksivitaminon D2 in 25-hidroksivitaminom D3
|
|
US20100009949A1
(en)
*
|
2006-03-24 |
2010-01-14 |
Bioxell S.P.A. |
Novel method
|
|
DK3357496T3
(da)
|
2006-06-21 |
2020-05-11 |
Opko Ireland Global Holdings Ltd |
Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
|
|
PT2148684E
(pt)
*
|
2007-04-25 |
2013-04-19 |
Cytochroma Inc |
Método de tratamento para a insuficiência e deficiência de vitamina d
|
|
CA2684778C
(en)
*
|
2007-04-25 |
2017-09-05 |
Cytochroma Inc. |
Methods and compounds for vitamin d therapy
|
|
PT2148661E
(pt)
*
|
2007-04-25 |
2013-03-06 |
Proventiv Therapeutics Llc |
Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
|
|
ES3047207T3
(en)
|
2007-04-25 |
2025-12-03 |
Opko Renal Llc |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
|
US8221803B1
(en)
|
2007-06-25 |
2012-07-17 |
OncoNatural Solutions, Inc. |
Composition for prostate health
|
|
CN106853250A
(zh)
|
2008-04-02 |
2017-06-16 |
赛特克罗公司 |
用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
|
|
US20100158998A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Michael Fox |
Formulations comprising vitamin d or derivatives thereof
|
|
DK3045043T3
(da)
|
2009-02-26 |
2020-08-03 |
Relmada Therapeutics Inc |
Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
|
|
US11672809B2
(en)
|
2010-03-29 |
2023-06-13 |
Eirgen Pharma Ltd. |
Methods and compositions for reducing parathyroid levels
|
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
|
US8999393B1
(en)
*
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
CN103142553B
(zh)
*
|
2013-03-21 |
2014-10-01 |
青岛正大海尔制药有限公司 |
一种骨化三醇缓释胶囊及其制备方法
|
|
CN103142555B
(zh)
*
|
2013-03-21 |
2014-10-01 |
青岛正大海尔制药有限公司 |
一种阿法骨化醇缓释胶囊及其制备方法
|
|
CN103142537B
(zh)
*
|
2013-03-21 |
2014-11-12 |
青岛正大海尔制药有限公司 |
骨化三醇缓释剂片
|
|
CN103142554B
(zh)
*
|
2013-03-21 |
2014-11-12 |
青岛正大海尔制药有限公司 |
骨化三醇控释胶囊及其制备方法
|
|
JP6282939B2
(ja)
*
|
2014-06-05 |
2018-02-21 |
株式会社ファンケル |
耐酸性錠剤
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
TW201618783A
(zh)
|
2014-08-07 |
2016-06-01 |
艾森塔製藥公司 |
以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
|
|
WO2017182237A1
(en)
|
2016-03-28 |
2017-10-26 |
Opko Ireland Global Holdings, Limited |
Methods of vitamin d treatment
|
|
KR102121400B1
(ko)
*
|
2018-07-31 |
2020-06-17 |
(주)에이치케이바이오텍 |
신령버섯균사체 액체배양 추출물을 포함하는 전립선 비대증의 예방 또는 치료용 조성물
|
|
PE20211489A1
(es)
|
2018-08-31 |
2021-08-11 |
Opko Ireland Global Holdings Ltd |
Formas de dosificacion pediatricas de vitamina d, metodos de elaboracion y uso
|
|
IT201900003843A1
(it)
*
|
2019-03-15 |
2020-09-15 |
Lo Li Pharma Srl |
Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG)
|
|
CN110917163A
(zh)
*
|
2019-12-11 |
2020-03-27 |
正大制药（青岛）有限公司 |
一种帕立骨化醇固体口服制剂
|
|
CN110917169A
(zh)
*
|
2019-12-11 |
2020-03-27 |
正大制药（青岛）有限公司 |
帕立骨化醇胶囊剂及其制备方法
|